Breast Cancer Clinical Trial
The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments
Summary
This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.
Eligibility Criteria
Inclusion Criteria:
Patient currently is undergoing treatment for cancer
Patient has menopausal symptoms induced either by surgical or medical (patient on tamoxifen or aromatase inhibitor) interventions for cancer
> 18 years of age
Willing to travel to a Legacy Health facility if necessary
Agree to attend study visits outside of standard of care visits, if needed
Willing to stop other supplements or medications that are aimed at treating menopausal symptoms at least 7 days before beginning study treatment
Willing to engage in pre/post testing and survey/phone calls
Exclusion Criteria:
Patient is currently undergoing chemotherapy treatment
< 18 years of age
Unable to comply with protocol
Unable to provide written informed consent
Investigator does not believe study participation is in the best interest of the patient
Patient had concurrent menopausal symptoms prior to the start of cancer treatment
Menopausal symptoms are unrelated to surgical or medical treatment of breast or gynecologic cancers
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.